CRYAA and metabolic disease: Because of the previously demonstrated anti-inflammatory role of HspB4/αA-crystallin in systemic inflammation, we hypothesized that HspB4/αA-crystallin plays a central role in the regulation of the inflammatory response of retinal MGCs during diabetes and metabolic disorders.